Trademark: 97920925
Status Date
Tuesday, March 19, 2024
Filing Date
Thursday, May 4, 2023
Published for Opposition
Tuesday, March 19, 2024
40 Custom manufacture of pharmaceuticals
5 Pharmaceutical preparations for the treatment of nausea and vomiting caused by cancer chemotherapy, radiation therapy, or surgery, and containing ondansetron; Pharmaceutical preparations for the treatment of angina by sublingual administration, namely, nitroglycerin tablets
42 Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development
Mar 19, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 19, 2024
Published For Opposition
Feb 28, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2024
Notification Of Notice Of Publication E-Mailed
Feb 19, 2024
Teas Change Of Correspondence Received
Feb 19, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 19, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 19, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 19, 2024
Teas Change Of Owner Address Received
Feb 9, 2024
Approved For Pub - Principal Register
Jan 30, 2024
Assigned To Examiner
Jun 4, 2023
New Application Office Supplied Data Entered
May 8, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24